Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

Clinical trial NCT05784428 · RECRUITING

Trial details

NCT number: NCT05784428
Sponsor: Robert Olson
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Oligometastatic Disease Oligoprogression Toxicity Due to Radiotherapy Quality of Life

Start date: 2025-04-16
Primary completion: 2035-04-30
Enrollment: 598

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.